Cellular populations and uses thereof
View Patent ↗Disclosed are methods of identifying immunosuppressive T R 1 regulatory T cells, including in methods of diagnosing the presence of immune tolerance, methods of producing immunosuppressive regulatory T cells, and methods of eliciting immune tolerance in a subject. These methods include screening T cells to detect Eomes + IL-10 + T cells or expressing recombinant Eomes in T cell populations to generate immunosuppressive regulatory T cells.
1. A method of producing a population of immunosuppressive regulatory T cells, the method comprising: isolating a heterogenous population of cells comprising regulatory T cells; enriching for IL-10 + CD4 + T cells that are optionally positive or high for at least one of CD122, α4β7, LAG-3, Ly6C and TIGIT, and/or optionally negative or low for one or more of CD25, CD69 and FoxP3; and introducing into the IL-10 + CD4 + T cells a construct comprising an Eomes coding sequence in operable connection with a regulatory sequence that is operable in the IL-10 + CD4 + T cells, to thereby produce a population of immunosuppressive regulatory T cells comprising Eomes + IL-10 + CD4 + T cells.
2. The method claim 1 , further comprising expanding the Eomes + IL-10 + CD4 + T cells.
3. The method of claim 2 , wherein the Eomes + IL-10 + CD4 + T cells are expanded by a process comprising contacting the Eomes + IL-10 + CD4 + T cells with an agent selected from the group consisting of an antigen, an alloantigen, an anti-CD3 antibody and an anti-CD28 antibody.
4. The method of claim 2 , wherein the Eomes + IL-10 + CD4 + T cells comprise Eomes + IL-10 + CD4 + T cells that are antigen-specific.
5. The method of claim 1 , wherein the Eomes + IL-10 + CD4 + T cells comprise Eomes hi T cells.
6. The method of claim 1 , wherein the Eomes + IL-10 + CD4 + T cells comprise Tbet lo T cells.
7. The method of claim 1 , wherein the Eomes + IL-10 + CD4 + T cells comprise IFNγ + T cells.
8. The method of claim 1 , wherein the Eomes + IL-10 + CD4 + T cells are high for one or both of IL-10 and IFNγ.
9. The method of claim 1 , wherein the Eomes + IL-10 + CD4 + T cells are negative or low for T H 2 cytokines.
10. The method of claim 1 , wherein the Eomes + IL-10 + CD4 + T cells are capable of suppressing at least one immune function selected from the group consisting of IL-2 production, cell proliferation, cytokine production, cell migration, and effector functions, killing, and T-cell proliferation.
11. A method of eliciting immune tolerance in a subject, the method comprising preparing a population of immunosuppressive regulatory T cells produced according to the method of claim 1 and administering the immunosuppressive regulatory T cells to the subject to thereby suppress an immune response in the subject.
12. The method of claim 11 , wherein the population of immunosuppressive regulatory T cells is autologous or allogeneic to the subject.
13. The method of claim 11 , wherein the subject has an immune or autoimmune disorder.